152 related articles for article (PubMed ID: 6772527)
1. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
Schmitz-Huebner U; Balleisen L; Arends P; Pollmann H; Sutor AH
Haemostasis; 1980; 9(4):204-13. PubMed ID: 6772527
[TBL] [Abstract][Full Text] [Related]
2. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
Takahashi H
Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
[No Abstract] [Full Text] [Related]
3. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
Mannucci PM; Canciani MT; Rota L; Donovan BS
Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
[TBL] [Abstract][Full Text] [Related]
4. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
[TBL] [Abstract][Full Text] [Related]
5. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
[TBL] [Abstract][Full Text] [Related]
6. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
Marwick C
JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
[No Abstract] [Full Text] [Related]
7. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S; Harris AS; Nilsson IM
Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
[TBL] [Abstract][Full Text] [Related]
8. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
Warrier AI; Lusher JM
J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
[TBL] [Abstract][Full Text] [Related]
10. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
Moffat EH; Giddings JC; Bloom AL
Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
[TBL] [Abstract][Full Text] [Related]
11. Intranasal fractionated administration of desamino-D-arginine vasopressin (DDAVP) in patients with von Willebrand's disease.
Garicochea B; D'Amico EA; Bydlowski SP; Chamone DA
Ann Hematol; 1991; 62(2-3):81-2. PubMed ID: 1903313
[No Abstract] [Full Text] [Related]
12. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
Casonato A; Sartori MT; Pontara E; Bertomoro A; Dannhäuser D; Girolami
Blood Coagul Fibrinolysis; 1991 Aug; 2(4):567-73. PubMed ID: 1768767
[TBL] [Abstract][Full Text] [Related]
13. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
Theiss W; Schmidt G
Thromb Res; 1978 Dec; 13(6):1119-23. PubMed ID: 311959
[No Abstract] [Full Text] [Related]
14. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
[TBL] [Abstract][Full Text] [Related]
15. Desamino-D-arginine vasopressin and bleeding time in von Willebrand's disease.
Isola L; Forster A; Aledort LM
Ann Intern Med; 1984 Nov; 101(5):719-20. PubMed ID: 6435493
[No Abstract] [Full Text] [Related]
16. DDAVP in haemophilia and von Willebrand's disease.
Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606
[No Abstract] [Full Text] [Related]
17. Diagnosis and management of von Willebrand's syndrome.
Rick ME
Med Clin North Am; 1994 May; 78(3):609-23. PubMed ID: 8170261
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
Bala L; Boggio L; Green D
Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
[No Abstract] [Full Text] [Related]
19. Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor.
Ball J; Malia RG; Greaves M; Preston FE
Br J Haematol; 1987 Jan; 65(1):95-100. PubMed ID: 3101732
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]